| BBB | Blood–brain barrier |
| CNN | Convolutional Neural Network |
| CT | Computed Tomography |
| CTV | Clinical Target Volume |
| DSC | Dice-Sørensen-Coefficient |
| FET | O-(2)-18F-Fluoroethyl-L-Tyrosine |
| FLAIR | T2-weighted fluid-attenuated inversion recovery (magnetic resonance sequence) |
| GBM | Glioblastoma |
| GT | Ground Truth |
| HD | Hausdorff Distance |
| MR | Magnetic Resonance |
| MR∩PET | MR-Enhancing regions with PET-Uptake overlap |
| MR-Only | MR-Enhancing regions without PET-Uptake overlap |
| OARs | Organs at Risk |
| PC | Prospective Cohort |
| PET | Positron Emission Tomography |
| PPV | Positive Predictive Value |
| PTV | Planning Target Volume |
| RC | Retrospective Cohort |
| RF | Radiomic Features |
| RT | Radiation Therapy |
| T1wCE | Contrast-enhanced T1-weighted (magnetic resonance sequence) |
| WSRT | Wilcoxon signed-rank test |